NEW
YORK, Jan. 10, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law
firm, is investigating potential claims related to the below-listed
proposed mergers. Kuehn Law
may seek additional disclosures or other relief on behalf of the
shareholders of these companies.
Kuehn Law is investigating
whether the Boards of the below companies 1) acted to maximize
shareholder value, 2) failed to disclose material information, and
3) conducted a fair process:
- Ambrx Biopharma, Inc. (Nasdaq: AMAM)
Johnson & Johnson has agreed to acquire Ambrx Biopharma,
Inc. in a transaction valued at an estimated $2.0 billion. Under the agreement, shareholders
of Ambrx Biopharma, Inc. will be entitled to a payment of
$28.00 per share in cash.
- Harpoon Therapeutics, Inc. (Nasdaq: HARP)
Merck has agreed to acquire Harpoon Therapeutics. Under
the terms of the agreement, Harpoon shareholders will receive
$23.00 per share in cash.
- Axonics, Inc. (Nasdaq: AXNX)
Axonics has agreed to be acquired by Boston Scientific. The
acquisition, set at $71 per share in
cash, represents an overall equity value of approximately
$3.7 billion.
- Callon Petroleum Company (NYSE: CPE)
APA Corporation has agreed to acquire Callon Petroleum Company.
This acquisition is valued at approximately $4.5 billion. Under the proposed transaction each
share of Callon Petroleum common stock will be exchanged for a
fixed ratio of 1.0425 shares of APA common stock.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved,
you contribute to the integrity and fairness of the financial
markets. Your investment. Your voice. Your future.™
How to Get Involved:
Kuehn Law is dedicated to
safeguarding shareholder interests. Concerned shareholders are
encouraged to contact Justin Kuehn,
Esq., at justin@kuehn.law or call (833) 672-0814.
Kuehn Law covers all case costs
and does not charge its investor clients. Shareholders
are advised to act promptly, as legal rights may be
time-sensitive.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download
multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-amam-harp-axnx-and-cpe-investors-to-contact-law-firm-302031830.html
SOURCE Kuehn Law, PLLC